Fernando C. Fervenza

Mayo Clinic — United States

Medicine · Health Sciences

96h-index38.1kcitations592works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(352), Vasculitis and related conditions(176), Amyloidosis: Diagnosis, Treatment, Outcomes(108), Chronic Kidney Disease and Diabetes(97), Coagulation, Bradykinin, Polyphosphates, and Angioedema(74)

Publications573 total

Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN
New England Journal of Medicine·2025· 1 cited
Dual-antigen membranous nephropathy
Kidney International·2025
What’s New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A Review
American Journal of Kidney Diseases·2025· 1 cited
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis
Nature Reviews Rheumatology·2025· 1 cited
Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis
Kidney International Reports·2025Open Access
Long-Term Follow-Up of a Pure Class V Lupus Nephritis Cohort at Mayo Clinic
Journal of the American Society of Nephrology·2025
Phase 2 Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab (OBI) in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Steroids: A Two-Year Study
Journal of the American Society of Nephrology·2025
#2027 Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
Nephrology Dialysis Transplantation·2025
Under Pressure: Rethinking Plasma Exchange in the Management of ANCA-Associated Vasculitis with Alveolar Hemorrhage
Journal of the American Society of Nephrology·2025
Laser Microdissection and Mass Spectrometry Shows Loss of Podocyte Proteins in Minimal Change Disease and FSGS
Journal of the American Society of Nephrology·2025
#1075 Cancer incidence and risk factors in PLA2R-associated membranous nephropathy
Nephrology Dialysis Transplantation·2025Open Access
Laser Microdissection and Mass Spectrometry Analysis of Complement in Membranous Nephropathy (MN)
Journal of the American Society of Nephrology·2025
Comorbidities, Biopsy Characteristics, and Kidney Outcomes in a Cohort of Patients with DNAJB9-Positive Fibrillary Glomerulonephritis
Journal of the American Society of Nephrology·2025
Antiproteinuric Effect of SGLT2 Inhibitors in Nondiabetic Glomerulopathies Is Dependent on Body Mass Index
Journal of the American Society of Nephrology·2025
Anti-dsDNA Serological Status in Proliferative Lupus Nephritis
Journal of the American Society of Nephrology·2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
Nephrology Dialysis Transplantation·2025· 2 citedOpen Access
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation
BioDrugs·2025
Acute Interstitial Nephritis Induced by Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)—Unveiling a New Association: A Case Report
Kidney Medicine·2025Open Access
Monoclonal Gammopathy in ANCA-Negative Pauci-Immune Crescentic GN
Kidney360·2025· 1 citedOpen Access
Antigens in membranous nephropathy: discovery and clinical implications
Nature Reviews Nephrology·2025· 9 cited
page 1 of 29Next →

Frequent Co-authors

Sanjeev Sethi(22), Nelson Leung(12), Gerald B. Appel(11), Ulrich Specks(10), Agnes B. Fogo(10), Vivette D. D’Agati(9), Daniel Cattran(9), Brad H. Rovin(8), Pierre Ronco(8), Jonathan Barratt(7), Richard J. Glassock(7), Heather N. Reich(7), Charles E. Alpers(7), Mark Haas(7), Zhihong Liu(6), Marina Vivarelli(6), Jack F.M. Wetzels(6), Rosanna Coppo(6), S. A. Roberts(6), Andrew M. Herzenberg(6)